Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database
about
A narrative review of microbial biofilm in postoperative surgical site infections: clinical presentation and treatment.Penetration of daptomycin into bone and synovial fluid in joint replacement.Comparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates.Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference centerA retrospective study of outcomes of device-associated osteomyelitis treated with daptomycin.Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE)Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry.Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE.Daptomycin for the treatment of major gram-positive infections after cardiac surgery.Approach to chronic wound infections.Daptomycin plus fosfomycin, a synergistic combination in experimental implant-associated osteomyelitis due to methicillin-resistant Staphylococcus aureus in rats.Successful Daptomycin Use in a Pediatric Patient With Acute, Bilateral Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus.Acute bacterial sternoclavicular osteomyelitis in a long-term renal transplant recipient.Reply to Werth et al.msaABCR operon is involved in persister cell formation in Staphylococcus aureus.Periprosthetic joint infections: clinical and bench research.
P2860
Q30240106-DB098020-A7F8-4682-BAF6-B0B650E9915FQ33798246-90EEF3F9-1F1A-4919-B2D6-ED5D42AB1CACQ34596619-D836284A-D9AE-47D4-8C66-FD06EC68786AQ35926840-D3F04A94-4BE0-4D37-89D4-FDACBB128A63Q36061532-97344624-2200-4326-86C5-C0431B61D0ADQ36073392-44C37CF6-0E87-42A3-9992-E4B377E460A8Q36456328-145A4A7D-779C-4EA1-A27E-CA3DFAACCC3BQ36686882-DDBAD6CA-594C-4204-A950-0D725C089C43Q37150644-81A716EC-B634-4A81-8B6A-EDF7A4EB84CFQ38378865-B3BAC8F1-C12F-4707-A379-7B5A81AD1CF4Q39182290-49B3C56B-3CC7-4199-99CE-110D854A621CQ40425288-7D5598E8-2761-4483-8379-409EEBA13A01Q40630717-548D3DDA-E355-4ED5-B911-05F9888B4D95Q46430565-D968807E-400F-431F-B3A2-A806A97F362CQ47107925-591B74FC-F684-4412-84BD-E1604342B749Q53663173-B8D05CB4-A9A9-428E-A936-ABA649A0EB61
P2860
Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Daptomycin use in patients wit ...... from the EU-CORE(SM) database
@en
type
label
Daptomycin use in patients wit ...... from the EU-CORE(SM) database
@en
prefLabel
Daptomycin use in patients wit ...... from the EU-CORE(SM) database
@en
P2093
P2860
P356
P1476
Daptomycin use in patients wit ...... from the EU-CORE(SM) database
@en
P2093
Enzo Petrelli
Konstantinos N Malizos
Markus Heep
Panagiotis Gargalianos-Kakolyris
Pierluigi Viale
R Andrew Seaton
Rashidkhan Pathan
Ricardo L Chaves
Teresa Santantonio
P2860
P304
P356
10.1093/JAC/DKT067
P407
P577
2013-03-20T00:00:00Z